Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japanese institute develops bone replacement:

This article was originally published in Clinica

Executive Summary

A new bone replacement material with the same strength and elasticity as human bone has been developed by the National Institute for Research in Inorganic Material in Japan. The bioresorbable material is composed of calcium phosphate bonded to polylactic-acid and the Tokyo Medical and Dental University cooperated in a dog study that proved the material's nontoxicity. Human studies are expected to begin within three years, reports Japan Chemical Week (August 29th).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT089001

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel